http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2464984-C2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e245559d2ef02587585552747a7c7d24 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415 |
filingDate | 2007-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2012-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72def64cd5e2657ebf6be665f6ede4cd |
publicationDate | 2012-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2464984-C2 |
titleOfInvention | Non-steroid anti-inflammatory drug |
abstract | FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to pharmaceutical industry. The drug contains meloxicam as an active substance, and sodium chloride, glycine, glycofurol (tetraglycol), poloxamer (lutrol), methyl glucamine, sodium hydroxide and water for injections in the amounts specified in the patent claim. The relation of glycofurol and poloxamer makes 2:1. n EFFECT: invention provides preparing a new dosage form of meloxicam - a solution for intramuscular introduction in the integrated treatment of arthropathies accompanied by pain syndrome. |
priorityDate | 2007-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.